University of Colorado Cancer Center
ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Trial - Neoadjuvant Treatment With Enfortumab Vedotin Monotherapy in Cisplatin-Ineligible Patients With MIBC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Thomas Flaig
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Thomas Flaig
Login to view comments.
Click here to Login
Videos